nodes	percent_of_prediction	percent_of_DWPC	metapath
Fludrocortisone—AR—duct of salivary gland—head and neck cancer	0.234	0.571	CbGeAlD
Fludrocortisone—Erythema facial—Hydroxyurea—head and neck cancer	0.0592	0.137	CcSEcCtD
Fludrocortisone—Atrophy—Hydroxyurea—head and neck cancer	0.0332	0.0768	CcSEcCtD
Fludrocortisone—Cutaneous hypersensitivity—Docetaxel—head and neck cancer	0.023	0.0532	CcSEcCtD
Fludrocortisone—Skin hyperpigmentation—Hydroxyurea—head and neck cancer	0.0182	0.0421	CcSEcCtD
Fludrocortisone—Peptic ulcer—Vinblastine—head and neck cancer	0.0177	0.041	CcSEcCtD
Fludrocortisone—NR3C2—parotid gland—head and neck cancer	0.0146	0.0357	CbGeAlD
Fludrocortisone—NR3C2—saliva-secreting gland—head and neck cancer	0.014	0.0342	CbGeAlD
Fludrocortisone—Skin hyperpigmentation—Fluorouracil—head and neck cancer	0.0131	0.0303	CcSEcCtD
Fludrocortisone—NR3C2—connective tissue—head and neck cancer	0.0129	0.0314	CbGeAlD
Fludrocortisone—Amenorrhoea—Hydroxyurea—head and neck cancer	0.0123	0.0285	CcSEcCtD
Fludrocortisone—NR3C2—Nuclear Receptor transcription pathway—RARB—head and neck cancer	0.0119	0.0829	CbGpPWpGaD
Fludrocortisone—NR3C2—trachea—head and neck cancer	0.0108	0.0264	CbGeAlD
Fludrocortisone—Neoplasm—Vinblastine—head and neck cancer	0.0107	0.0248	CcSEcCtD
Fludrocortisone—NR3C1—Transcription factor regulation in adipogenesis—CEBPA—head and neck cancer	0.0106	0.0735	CbGpPWpGaD
Fludrocortisone—Menstruation irregular—Docetaxel—head and neck cancer	0.0101	0.0235	CcSEcCtD
Fludrocortisone—Rash maculo-papular—Hydroxyurea—head and neck cancer	0.00982	0.0227	CcSEcCtD
Fludrocortisone—Neoplasm—Hydroxyurea—head and neck cancer	0.00977	0.0226	CcSEcCtD
Fludrocortisone—NR3C1—neck—head and neck cancer	0.00962	0.0235	CbGeAlD
Fludrocortisone—AR—connective tissue—head and neck cancer	0.00952	0.0233	CbGeAlD
Fludrocortisone—Skin hyperpigmentation—Docetaxel—head and neck cancer	0.00944	0.0219	CcSEcCtD
Fludrocortisone—AR—epithelium—head and neck cancer	0.00904	0.0221	CbGeAlD
Fludrocortisone—NR3C2—thyroid gland—head and neck cancer	0.00854	0.0209	CbGeAlD
Fludrocortisone—NR3C1—parotid gland—head and neck cancer	0.00783	0.0191	CbGeAlD
Fludrocortisone—Dermatitis atopic—Docetaxel—head and neck cancer	0.00759	0.0176	CcSEcCtD
Fludrocortisone—NR3C2—head—head and neck cancer	0.00757	0.0185	CbGeAlD
Fludrocortisone—NR3C1—saliva-secreting gland—head and neck cancer	0.0075	0.0183	CbGeAlD
Fludrocortisone—Oesophagitis—Fluorouracil—head and neck cancer	0.00711	0.0165	CcSEcCtD
Fludrocortisone—Rash maculo-papular—Fluorouracil—head and neck cancer	0.00707	0.0164	CcSEcCtD
Fludrocortisone—AR—Nuclear Receptors—RARB—head and neck cancer	0.007	0.0487	CbGpPWpGaD
Fludrocortisone—AR—lymphoid tissue—head and neck cancer	0.00696	0.017	CbGeAlD
Fludrocortisone—AR—Regulation of Androgen receptor activity—CEBPA—head and neck cancer	0.0069	0.048	CbGpPWpGaD
Fludrocortisone—NR3C1—connective tissue—head and neck cancer	0.00689	0.0168	CbGeAlD
Fludrocortisone—Pancreatitis—Hydroxyurea—head and neck cancer	0.00665	0.0154	CcSEcCtD
Fludrocortisone—NR3C1—epithelium—head and neck cancer	0.00655	0.016	CbGeAlD
Fludrocortisone—Thrombophlebitis—Fluorouracil—head and neck cancer	0.00652	0.0151	CcSEcCtD
Fludrocortisone—Amenorrhoea—Docetaxel—head and neck cancer	0.00639	0.0148	CcSEcCtD
Fludrocortisone—AR—thyroid gland—head and neck cancer	0.00632	0.0154	CbGeAlD
Fludrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—CEBPA—head and neck cancer	0.00607	0.0422	CbGpPWpGaD
Fludrocortisone—Haemoglobin—Vinblastine—head and neck cancer	0.00598	0.0138	CcSEcCtD
Fludrocortisone—Haemorrhage—Vinblastine—head and neck cancer	0.00595	0.0138	CcSEcCtD
Fludrocortisone—NR3C1—trachea—head and neck cancer	0.00579	0.0141	CbGeAlD
Fludrocortisone—AR—head—head and neck cancer	0.00561	0.0137	CbGeAlD
Fludrocortisone—AR—Nuclear Receptor transcription pathway—RARB—head and neck cancer	0.00553	0.0385	CbGpPWpGaD
Fludrocortisone—Haemoglobin—Hydroxyurea—head and neck cancer	0.00545	0.0126	CcSEcCtD
Fludrocortisone—Haemorrhage—Hydroxyurea—head and neck cancer	0.00543	0.0126	CcSEcCtD
Fludrocortisone—Fluid retention—Docetaxel—head and neck cancer	0.00533	0.0123	CcSEcCtD
Fludrocortisone—NR3C1—Nuclear Receptors—RARB—head and neck cancer	0.00531	0.0369	CbGpPWpGaD
Fludrocortisone—NR3C2—lymph node—head and neck cancer	0.0053	0.013	CbGeAlD
Fludrocortisone—NR3C1—Regulation of Androgen receptor activity—CEBPA—head and neck cancer	0.00523	0.0364	CbGpPWpGaD
Fludrocortisone—Oesophagitis—Docetaxel—head and neck cancer	0.00513	0.0119	CcSEcCtD
Fludrocortisone—Neoplasm—Docetaxel—head and neck cancer	0.00508	0.0118	CcSEcCtD
Fludrocortisone—NR3C1—lymphoid tissue—head and neck cancer	0.00504	0.0123	CbGeAlD
Fludrocortisone—Muscular weakness—Fluorouracil—head and neck cancer	0.00498	0.0115	CcSEcCtD
Fludrocortisone—Erythema—Hydroxyurea—head and neck cancer	0.00472	0.0109	CcSEcCtD
Fludrocortisone—Thrombophlebitis—Docetaxel—head and neck cancer	0.00471	0.0109	CcSEcCtD
Fludrocortisone—Vertigo—Vinblastine—head and neck cancer	0.00465	0.0108	CcSEcCtD
Fludrocortisone—NR3C1—thyroid gland—head and neck cancer	0.00458	0.0112	CbGeAlD
Fludrocortisone—Cardiac failure congestive—Docetaxel—head and neck cancer	0.00449	0.0104	CcSEcCtD
Fludrocortisone—Convulsion—Vinblastine—head and neck cancer	0.00449	0.0104	CcSEcCtD
Fludrocortisone—Clobetasol propionate—CYP1A1—head and neck cancer	0.00448	0.303	CrCbGaD
Fludrocortisone—Hypertension—Vinblastine—head and neck cancer	0.00447	0.0104	CcSEcCtD
Fludrocortisone—NR3C1—Nuclear Receptor transcription pathway—RARB—head and neck cancer	0.0042	0.0292	CbGpPWpGaD
Fludrocortisone—Convulsion—Hydroxyurea—head and neck cancer	0.00409	0.00948	CcSEcCtD
Fludrocortisone—NR3C1—head—head and neck cancer	0.00406	0.00992	CbGeAlD
Fludrocortisone—NR3C2—Preimplantation Embryo—CDH1—head and neck cancer	0.00397	0.0276	CbGpPWpGaD
Fludrocortisone—AR—lymph node—head and neck cancer	0.00393	0.00959	CbGeAlD
Fludrocortisone—Haemoglobin—Fluorouracil—head and neck cancer	0.00393	0.00909	CcSEcCtD
Fludrocortisone—Haemorrhage—Fluorouracil—head and neck cancer	0.00391	0.00904	CcSEcCtD
Fludrocortisone—Oedema—Hydroxyurea—head and neck cancer	0.00386	0.00893	CcSEcCtD
Fludrocortisone—Infection—Hydroxyurea—head and neck cancer	0.00383	0.00887	CcSEcCtD
Fludrocortisone—Erythema—Fluorouracil—head and neck cancer	0.0034	0.00787	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—XRCC3—head and neck cancer	0.00335	0.0233	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Vinblastine—head and neck cancer	0.00311	0.00721	CcSEcCtD
Fludrocortisone—Asthenia—Vinblastine—head and neck cancer	0.00303	0.00702	CcSEcCtD
Fludrocortisone—Convulsion—Fluorouracil—head and neck cancer	0.00295	0.00682	CcSEcCtD
Fludrocortisone—Myalgia—Fluorouracil—head and neck cancer	0.0029	0.0067	CcSEcCtD
Fludrocortisone—NR3C1—lymph node—head and neck cancer	0.00284	0.00695	CbGeAlD
Fludrocortisone—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00284	0.00658	CcSEcCtD
Fludrocortisone—Haemoglobin—Docetaxel—head and neck cancer	0.00283	0.00656	CcSEcCtD
Fludrocortisone—Haemorrhage—Docetaxel—head and neck cancer	0.00282	0.00653	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Fluorouracil—head and neck cancer	0.00278	0.00643	CcSEcCtD
Fludrocortisone—Oedema—Fluorouracil—head and neck cancer	0.00278	0.00643	CcSEcCtD
Fludrocortisone—Asthenia—Hydroxyurea—head and neck cancer	0.00277	0.0064	CcSEcCtD
Fludrocortisone—Infection—Fluorouracil—head and neck cancer	0.00276	0.00638	CcSEcCtD
Fludrocortisone—Headache—Vinblastine—head and neck cancer	0.00265	0.00613	CcSEcCtD
Fludrocortisone—NR3C1—Adipogenesis—CEBPA—head and neck cancer	0.00255	0.0178	CbGpPWpGaD
Fludrocortisone—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00253	0.00585	CcSEcCtD
Fludrocortisone—Insomnia—Fluorouracil—head and neck cancer	0.00251	0.00581	CcSEcCtD
Fludrocortisone—Erythema—Docetaxel—head and neck cancer	0.00245	0.00568	CcSEcCtD
Fludrocortisone—AR—Notch-mediated HES/HEY network—NOTCH1—head and neck cancer	0.00242	0.0168	CbGpPWpGaD
Fludrocortisone—Headache—Hydroxyurea—head and neck cancer	0.00242	0.00559	CcSEcCtD
Fludrocortisone—Urticaria—Fluorouracil—head and neck cancer	0.0022	0.0051	CcSEcCtD
Fludrocortisone—Triamcinolone—PTGS2—head and neck cancer	0.0022	0.149	CrCbGaD
Fludrocortisone—Convulsion—Docetaxel—head and neck cancer	0.00213	0.00492	CcSEcCtD
Fludrocortisone—Hypertension—Docetaxel—head and neck cancer	0.00212	0.00491	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—RAD51—head and neck cancer	0.00211	0.0147	CbGpPWpGaD
Fludrocortisone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK3—head and neck cancer	0.0021	0.0146	CbGpPWpGaD
Fludrocortisone—Myalgia—Docetaxel—head and neck cancer	0.00209	0.00484	CcSEcCtD
Fludrocortisone—NR3C2—Generic Transcription Pathway—RARB—head and neck cancer	0.00206	0.0143	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Fluorouracil—head and neck cancer	0.00204	0.00473	CcSEcCtD
Fludrocortisone—NR3C1—Adipogenesis—STAT6—head and neck cancer	0.00204	0.0142	CbGpPWpGaD
Fludrocortisone—Oedema—Docetaxel—head and neck cancer	0.002	0.00464	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Docetaxel—head and neck cancer	0.002	0.00464	CcSEcCtD
Fludrocortisone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK1—head and neck cancer	0.002	0.0139	CbGpPWpGaD
Fludrocortisone—Infection—Docetaxel—head and neck cancer	0.00199	0.00461	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	0.00192	0.0134	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—YAP1—head and neck cancer	0.00187	0.013	CbGpPWpGaD
Fludrocortisone—AR—Nongenotropic Androgen signaling—MAPK3—head and neck cancer	0.00187	0.013	CbGpPWpGaD
Fludrocortisone—Progesterone—CYP1A1—head and neck cancer	0.00183	0.124	CrCbGaD
Fludrocortisone—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.00183	0.00423	CcSEcCtD
Fludrocortisone—Insomnia—Docetaxel—head and neck cancer	0.00181	0.00419	CcSEcCtD
Fludrocortisone—Betamethasone—PTGS2—head and neck cancer	0.0018	0.122	CrCbGaD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—CASP8—head and neck cancer	0.00179	0.0124	CbGpPWpGaD
Fludrocortisone—AR—Nongenotropic Androgen signaling—MAPK1—head and neck cancer	0.00178	0.0124	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	0.00175	0.0122	CbGpPWpGaD
Fludrocortisone—Headache—Fluorouracil—head and neck cancer	0.00174	0.00403	CcSEcCtD
Fludrocortisone—Testosterone—CYP1A1—head and neck cancer	0.00173	0.117	CrCbGaD
Fludrocortisone—Dexamethasone—CYP1A1—head and neck cancer	0.00168	0.114	CrCbGaD
Fludrocortisone—AR—Nongenotropic Androgen signaling—PIK3CA—head and neck cancer	0.00154	0.0107	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Docetaxel—head and neck cancer	0.00148	0.00342	CcSEcCtD
Fludrocortisone—Asthenia—Docetaxel—head and neck cancer	0.00144	0.00333	CcSEcCtD
Fludrocortisone—AR—Nongenotropic Androgen signaling—HRAS—head and neck cancer	0.00143	0.00993	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—head and neck cancer	0.00142	0.0099	CbGpPWpGaD
Fludrocortisone—AR—Notch-mediated HES/HEY network—STAT3—head and neck cancer	0.0014	0.00975	CbGpPWpGaD
Fludrocortisone—NR3C1—Endoderm Differentiation—NOTCH1—head and neck cancer	0.00137	0.00951	CbGpPWpGaD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—CCND1—head and neck cancer	0.00132	0.00917	CbGpPWpGaD
Fludrocortisone—AR—Nongenotropic Androgen signaling—AKT1—head and neck cancer	0.00126	0.00876	CbGpPWpGaD
Fludrocortisone—Headache—Docetaxel—head and neck cancer	0.00125	0.00291	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—head and neck cancer	0.00106	0.00738	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	0.00105	0.00731	CbGpPWpGaD
Fludrocortisone—Dexamethasone—PTGS2—head and neck cancer	0.00105	0.071	CrCbGaD
Fludrocortisone—NR3C2—Gene Expression—RARB—head and neck cancer	0.000991	0.00689	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—CCND1—head and neck cancer	0.000975	0.00678	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—RARB—head and neck cancer	0.000956	0.00664	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—PTEN—head and neck cancer	0.000941	0.00654	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—IL2—head and neck cancer	0.000919	0.00639	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—YAP1—head and neck cancer	0.000902	0.00627	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—CCND1—head and neck cancer	0.000896	0.00623	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—YAP1—head and neck cancer	0.000869	0.00604	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—CASP8—head and neck cancer	0.000867	0.00603	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—PTEN—head and neck cancer	0.000865	0.00601	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—CDH1—head and neck cancer	0.000857	0.00596	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—NOTCH1—head and neck cancer	0.000844	0.00587	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—STAT3—head and neck cancer	0.000841	0.00585	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—IL2—head and neck cancer	0.00081	0.00563	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—EGFR—head and neck cancer	0.000765	0.00532	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—BCL2—head and neck cancer	0.000744	0.00517	CbGpPWpGaD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—AKT1—head and neck cancer	0.000733	0.0051	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—RARB—head and neck cancer	0.000725	0.00504	CbGpPWpGaD
Fludrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—head and neck cancer	0.000723	0.00502	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	0.000718	0.00499	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—YAP1—head and neck cancer	0.00066	0.00459	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—head and neck cancer	0.000651	0.00453	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—CCND1—head and neck cancer	0.000639	0.00444	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—head and neck cancer	0.00062	0.00431	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	0.000616	0.00429	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—PTEN—head and neck cancer	0.000616	0.00429	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—TP53—head and neck cancer	0.00059	0.0041	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	0.000586	0.00407	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—head and neck cancer	0.000585	0.00406	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—VEGFA—head and neck cancer	0.000557	0.00387	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	0.000542	0.00377	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—AKT1—head and neck cancer	0.000542	0.00377	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	0.000529	0.00368	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—TP53—head and neck cancer	0.00052	0.00362	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	0.000511	0.00355	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—MAPK1—head and neck cancer	0.000501	0.00348	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—EGFR—head and neck cancer	0.000501	0.00348	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—STAT3—head and neck cancer	0.000471	0.00328	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	0.000461	0.00321	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—RARB—head and neck cancer	0.00046	0.0032	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—head and neck cancer	0.000444	0.00308	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—head and neck cancer	0.000439	0.00305	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	0.000436	0.00303	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—TP53—head and neck cancer	0.000421	0.00292	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—YAP1—head and neck cancer	0.000419	0.00291	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	0.000415	0.00289	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	0.000415	0.00289	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	0.000411	0.00286	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—NOTCH1—head and neck cancer	0.000407	0.00283	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—NOTCH1—head and neck cancer	0.000392	0.00272	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	0.00036	0.00251	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—AKT1—head and neck cancer	0.000355	0.00247	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—RARB—head and neck cancer	0.000349	0.00243	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	0.000349	0.00242	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—YAP1—head and neck cancer	0.000318	0.00221	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—NOTCH1—head and neck cancer	0.000297	0.00207	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	0.000294	0.00205	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—MAPK3—head and neck cancer	0.000225	0.00156	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—NOTCH1—head and neck cancer	0.000189	0.00131	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—AKT1—head and neck cancer	0.000152	0.00105	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—NOTCH1—head and neck cancer	0.000143	0.000995	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—MAPK3—head and neck cancer	0.000104	0.000726	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—MAPK3—head and neck cancer	7.92e-05	0.000551	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—AKT1—head and neck cancer	7.04e-05	0.000489	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—AKT1—head and neck cancer	5.34e-05	0.000371	CbGpPWpGaD
